{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T05:24:03Z","timestamp":1770701043169,"version":"3.49.0"},"reference-count":65,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1097\/mnh.0b013e328365ba53","type":"journal-article","created":{"date-parts":[[2013,10,7]],"date-time":"2013-10-07T15:43:28Z","timestamp":1381160608000},"page":"669-674","source":"Crossref","is-referenced-by-count":25,"title":["Pros and cons of catheter lock solutions"],"prefix":"10.1097","volume":"22","author":[{"given":"Vandana D.","family":"Niyyar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charmaine E.","family":"Lok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-13-20210205","first-page":"245","article-title":"The importance of delay in cannulation after hemodialysis vascular access surgery.","volume":"74","author":"Diskin","year":"1996","journal-title":"Nephron"},{"key":"R3-13-20210205","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S0272-6386(99)70018-1","article-title":"Bacteremia associated with tunneled, cuffed hemodialysis catheters.","volume":"34","author":"Saad","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"R4-13-20210205","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.0894-0959.2004.17314.x","article-title":"Dysfunction of new catheters by old fibrin sheaths.","volume":"17","author":"Beathard","year":"2004","journal-title":"Semin Dial"},{"key":"R5-13-20210205","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2215\/CJN.01910507","article-title":"Catheter patency and function after catheter sheath disruption: a pilot study.","volume":"2","author":"Oliver","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"R6-13-20210205","first-page":"17","article-title":"Double lumen subclavian hemodialysis cannulas.","volume":"8","author":"Bregman","year":"1985","journal-title":"Int J Artif Organs"},{"key":"R7-13-20210205","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/00007611-198209000-00016","article-title":"Use of subclavian catheters for hemodialysis.","volume":"75","author":"Snider","year":"1982","journal-title":"South Med J"},{"key":"R8-13-20210205","first-page":"106","article-title":"The subclavian catheter in haemodialysis.","volume":"19","author":"Uldall","year":"1983","journal-title":"Proc Eur Dial Transplant Assoc"},{"key":"R9-13-20210205","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1525-139X.2007.00284.x","article-title":"Fluid mechanics and clinical success of central venous catheters for dialysis: answers to simple but persisting problems.","volume":"20","author":"Ash","year":"2007","journal-title":"Semin Dial"},{"key":"R10-13-20210205","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1525-139X.2008.00494.x","article-title":"Advances in tunneled central venous catheters for dialysis: design and performance.","volume":"21","author":"Ash","year":"2008","journal-title":"Semin Dial"},{"key":"R11-13-20210205","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1525-139X.2011.00991.x","article-title":"Catheter dysfunction: the role of lock solutions.","volume":"25","author":"Niyyar","year":"2012","journal-title":"Semin Dial"},{"key":"R12-13-20210205","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1086\/322972","article-title":"Biofilm formation: a clinically relevant microbiological process.","volume":"33","author":"Donlan","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R13-13-20210205","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.tim.2004.11.010","article-title":"Survival strategies of infectious biofilms.","volume":"13","author":"Fux","year":"2005","journal-title":"Trends Microbiol"},{"key":"R14-13-20210205","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1097\/00003246-200204000-00033","article-title":"Fibrin sheath enhances central venous catheter infection.","volume":"30","author":"Mehall","year":"2002","journal-title":"Crit Care Med"},{"key":"R15-13-20210205","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1200\/JCO.2005.05.002","article-title":"Infectious complications of central venous catheters increase the risk of catheter-related thrombosis in hematology patients: a prospective study.","volume":"23","author":"van Rooden","year":"2005","journal-title":"J Clin Oncol"},{"key":"R16-13-20210205","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1046\/j.1525-139X.2002.00084.x","article-title":"Biofilms and infection in dialysis patients.","volume":"15","author":"Dasgupta","year":"2002","journal-title":"Semin Dial"},{"key":"R17-13-20210205","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1161\/hq0701.093520","article-title":"AHA scientific statement: guide to anticoagulant therapy: heparin: a statement for healthcare professionals from the American Heart Association.","volume":"21","author":"Hirsh","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R18-13-20210205","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1093\/ndt\/gfm452","article-title":"Exit of catheter lock solutions from double lumen acute haemodialysis catheters: an in vitro study.","volume":"22","author":"Sungur","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"R19-13-20210205","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1093\/ndt\/16.10.2072","article-title":"Risk of heparin lock-related bleeding when using indwelling venous catheter in haemodialysis.","volume":"16","author":"Karaaslan","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"R20-13-20210205","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1525-139X.2007.00294.x","article-title":"Concentrated heparin lock is associated with major bleeding complications after tunneled hemodialysis catheter placement.","volume":"20","author":"Yevzlin","year":"2007","journal-title":"Semin Dial"},{"key":"R21-13-20210205","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/MAT.0b013e3180619519","article-title":"Concentration of heparin-locking solution and risk of central venous hemodialysis catheter malfunction.","volume":"53","author":"Thomas","year":"2007","journal-title":"ASAIO J"},{"key":"R22-13-20210205","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1542-4758.2007.00159.x","article-title":"Catheter lock heparin concentration: effects on tissue plasminogen activator use in tunneled cuffed catheters.","volume":"11","author":"Holley","year":"2007","journal-title":"Hemodial Int"},{"key":"R23-13-20210205","first-page":"1458","article-title":"Does the heparin lock concentration affect hemodialysis catheter patency Clin J Am Soc N","volume":"5","author":"Ivan","year":"2010","journal-title":"ephrol"},{"key":"R24-13-20210205","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1093\/ndt\/gfl170","article-title":"Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces.","volume":"21","author":"Shanks","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"R25-13-20210205","doi-asserted-by":"crossref","first-page":"4596","DOI":"10.1128\/IAI.73.8.4596-4606.2005","article-title":"Heparin stimulates Staphylococcus aureus biofilm formation.","volume":"73","author":"Shanks","year":"2005","journal-title":"Infect Immun"},{"key":"R26-13-20210205","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1525-139X.2008.00466.x","article-title":"Locking solutions for hemodialysis catheters; heparin and citrate--a position paper by ASDIN.","volume":"21","author":"Moran","year":"2008","journal-title":"Semin Dial"},{"key":"R27-13-20210205","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2215\/CJN.01760407","article-title":"Citrate 4 versus heparin and the reduction of thrombosis study (CHARTS).","volume":"3","author":"Macrae","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R28-13-20210205","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/ndt\/gfl606","article-title":"Sodium citrate 4 locking solution for central venous dialysis catheters: an effective, more cost-efficient alternative to heparin.","volume":"22","author":"Grudzinski","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"R29-13-20210205","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/ndt\/gfl570","article-title":"Trisodium citrate 4: an alternative to heparin capping of haemodialysis catheters.","volume":"22","author":"Lok","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"R30-13-20210205","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1046\/j.1525-1594.1998.06268.x","article-title":"Filling hemodialysis catheters in the interdialytic period: heparin versus citrate versus polygeline: a prospective randomized study.","volume":"22","author":"Buturovic","year":"1998","journal-title":"Artif Organs"},{"key":"R31-13-20210205","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1590\/S0101-28002011000100012","article-title":"Comparison of trisodium citrate and heparin as catheter-locking solution in hemodialysis patients.","volume":"33","author":"Bevilacqua","year":"2011","journal-title":"J Bras Nefrol"},{"key":"R32-13-20210205","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2146\/ajhp120300","article-title":"Sodium citrate 4 versus heparin as a lock solution in hemodialysis patients with central venous catheters.","volume":"70","author":"Yon","year":"2013","journal-title":"Am J Health Syst Pharm"},{"key":"R33-13-20210205","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1681\/ASN.2004100870","article-title":"Randomized, clinical trial comparison of trisodium citrate 30 and heparin as catheter-locking solution in hemodialysis patients.","volume":"16","author":"Weijmer","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R34-13-20210205","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1093\/ndt\/gfg481","article-title":"Risks related to catheter locking solutions containing concentrated citrate.","volume":"18","author":"Polaschegg","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"R35-13-20210205","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1053\/j.ajkd.2009.01.259","article-title":"Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial.","volume":"53","author":"Power","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"R36-13-20210205","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1093\/ndt\/gfs048","article-title":"Trisodium citrate induced protein precipitation in haemodialysis catheters might cause pulmonary embolism.","volume":"27","author":"Schilcher","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R37-13-20210205","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1053\/j.ajkd.2009.06.037","article-title":"Embolic complications from central venous hemodialysis catheters used with hypertonic citrate locking solution.","volume":"55","author":"Willicombe","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"R38-13-20210205","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1093\/ndt\/17.12.2189","article-title":"Superior antimicrobial activity of trisodium citrate over heparin for catheter locking.","volume":"17","author":"Weijmer","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"R39-13-20210205","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1053\/j.ajkd.2010.10.053","article-title":"Morphometric and biological characterization of biofilm in tunneled hemodialysis catheters.","volume":"57","author":"Jones","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"R40-13-20210205","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/ndt\/gfp651","article-title":"Reduction of biofilm formation with trisodium citrate in haemodialysis catheters: a randomized controlled trial.","volume":"25","author":"Bosma","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"R41-13-20210205","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1525-139X.2009.00685.x","article-title":"Risk of bacterial contamination from citrate catheter locks.","volume":"22","author":"Stranz","year":"2009","journal-title":"Semin Dial"},{"key":"R42-13-20210205","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1056\/NEJMoa1011376","article-title":"Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator.","volume":"364","author":"Hemmelgarn","year":"2011","journal-title":"N Engl J Med"},{"key":"R43-13-20210205","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/sdi.12115","article-title":"The economics of hemodialysis catheter-related infection prophylaxis.","volume":"26","author":"Daisy Kosa","year":"2013","journal-title":"Semin Dial"},{"key":"R44-13-20210205","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jhin.2011.07.010","article-title":"Efficacy of intravascular catheter lock solutions containing preservatives in the prevention of microbial colonization.","volume":"79","author":"Shenep","year":"2011","journal-title":"J Hosp Infect"},{"key":"R45-13-20210205","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/jac\/dkn284","article-title":"A prospective double-blind randomized trial comparing intraluminal ethanol with heparinized saline for the prevention of catheter-associated bloodstream infection in immunosuppressed haematology patients.","volume":"62","author":"Sanders","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"R46-13-20210205","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.jpedsurg.2010.05.014","article-title":"Preliminary results of a phase I trial of prophylactic ethanol-lock administration to prevent mediport catheter-related bloodstream infections.","volume":"45","author":"Kayton","year":"2010","journal-title":"J Pediatr Surg"},{"key":"R47-13-20210205","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/rcm.2837","article-title":"Mass spectrometry and scanning electron microscopy study of silicone tunneled dialysis catheter integrity after an exposure of 15 days to 60 ethanol solution.","volume":"21","author":"Guenu","year":"2007","journal-title":"Rapid Commun Mass Spectrom"},{"key":"R48-13-20210205","doi-asserted-by":"crossref","first-page":"369","DOI":"10.5414\/CNP62369","article-title":"Ethanoltrisodium citrate for hemodialysis catheter lock.","volume":"62","author":"Bell","year":"2004","journal-title":"Clin Nephrol"},{"key":"R49-13-20210205","doi-asserted-by":"crossref","first-page":"342","DOI":"10.5414\/CNP65342","article-title":"Effect of ethanoltrisodium citrate lock on the mechanical properties of carbothane hemodialysis catheters.","volume":"65","author":"Bell","year":"2006","journal-title":"Clinical nephrology"},{"key":"R50-13-20210205","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2369-10-23","article-title":"Rationale and design of the HEALTHY-CATH trial: a randomised controlled trial of heparin versus ethanol lock therapy for the prevention of catheter associated infection in haemodialysis patients.","volume":"10","author":"Broom","year":"2009","journal-title":"BMC Nephrol"},{"key":"R52-13-20210205","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1053\/j.ajkd.2009.11.025","article-title":"A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis.","volume":"55","author":"Solomon","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"R53-13-20210205","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1525-139X.2011.00951.x","article-title":"Observational study of need for thrombolytic therapy and incidence of bacteremia using taurolidine-citrate-heparin, taurolidine-citrate and heparin catheter locks in patients treated with hemodialysis.","volume":"25","author":"Solomon","year":"2012","journal-title":"Semin Dial"},{"key":"R54-13-20210205","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.ajkd.2011.08.031","article-title":"A randomized trial comparing gentamicincitrate and heparin locks for central venous catheters in maintenance hemodialysis patients.","volume":"59","author":"Moran","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"R55-13-20210205","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.2215\/CJN.01270210","article-title":"Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis.","volume":"5","author":"Landry","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R56-13-20210205","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1097\/01.ASN.0000022890.29656.22","article-title":"Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study.","volume":"13","author":"Dogra","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R57-13-20210205","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1525-139X.2011.00965.x","article-title":"Linezolid versus vancomycin antibiotic lock solution for the prevention of nontunneled catheter-related blood stream infections in hemodialysis patients: a prospective randomized study.","volume":"25","author":"Sofroniadou","year":"2012","journal-title":"Semin Dial"},{"key":"R58-13-20210205","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.ki.5000012","article-title":"Prevention of uncuffed hemodialysis catheter-related bacteremia using an antibiotic lock technique: a prospective, randomized clinical trial.","volume":"69","author":"Kim","year":"2006","journal-title":"Kidney Int"},{"key":"R59-13-20210205","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1523-1755.2004.00806.x","article-title":"Locking of tunneled hemodialysis catheters with gentamicin and heparin.","volume":"66","author":"McIntyre","year":"2004","journal-title":"Kidney Int"},{"key":"R60-13-20210205","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1053\/j.ajkd.2006.06.012","article-title":"Comparison of low-dose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremia.","volume":"48","author":"Nori","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"R61-13-20210205","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1440-1797.2006.00563.x","article-title":"Enhancing the survival of tunneled haemodialysis catheters using an antibiotic lock in the elderly: a randomised, double-blind clinical trial.","volume":"11","author":"Saxena","year":"2006","journal-title":"Nephrology (Carlton)"},{"key":"R62-13-20210205","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1681\/ASN.2010121306","article-title":"Minocycline-EDTA lock solution prevents catheter-related bacteremia in hemodialysis.","volume":"22","author":"Campos","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R63-13-20210205","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1086\/502578","article-title":"A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary hemodialysis access.","volume":"26","author":"Bleyer","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R64-13-20210205","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/j.ajkd.2007.12.003","article-title":"Prophylaxis against dialysis catheter-related bacteremia: a glimmer of hope.","volume":"51","author":"Allon","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"R66-13-20210205","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1093\/ndt\/gfm847","article-title":"Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials.","volume":"23","author":"Labriola","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"R67-13-20210205","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1093\/ndt\/gfn776","article-title":"Microbial inactivation properties of a new antimicrobialantithrombotic catheter lock solution (citratemethylene blueparabens).","volume":"24","author":"Steczko","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R68-13-20210205","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/CCM.0b013e318206b5a2","article-title":"A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: a multicenter, controlled, randomized trial.","volume":"39","author":"Maki","year":"2011","journal-title":"Crit Care Med"}],"container-title":["Current Opinion in Nephrology & Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MNH.0b013e328365ba53","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:30:12Z","timestamp":1620963012000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00041552-201311000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mnh.0b013e328365ba53","relation":{},"ISSN":["1062-4821"],"issn-type":[{"value":"1062-4821","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}